Table 4 Comparative assessment between the developed method and various baseline techniques applied to the SIIM-ISIC Melanoma dataset.
Method | Acc | Pr | Se | Sp | JI | F-S |
---|---|---|---|---|---|---|
Proposed method | 94.99 | 90.23 | 96.99 | 95.97 | 90.23 | 90.86 |
BD 36 | 76.99 | 79.99 | 87.00 | 82.98 | 80.90 | 84.52 |
miRNAs 38 | 81.97 | 76.98 | 90.01 | 84.16 | 84.52 | 86.15 |
OSVM 18 | 87.99 | 83.98 | 90.23 | 86.15 | 88.90 | 87.99 |
NN/WCO 39 | 91.65 | 83.99 | 92.37 | 90.23 | 88.79 | 90.23 |
CCNN 37 | 94.97 | 85.73 | 93.58 | 92.31 | 92.31 | 92.34 |